Phase 2 clinical trial of the proautophagic drug ABTL0812 combined with paclitaxel and carboplatin in first-line patients with advanced squamous non-small cell lung carcinoma.

paclitaxel - Generic mfg.

carboplatin - Generic mfg.

ibrilatazar (ABTL0812) - Ability Pharma

https://meetings.asco.org/abstracts-presentations/227148

Joaquim Bosch-Barrera; Teresa Moran; Purificación Estévez-García; Paloma Martín-Martorell; Renaud Sabatier; Ernest Nadal; Jose M. Lizcano; Oriol Pedrós-Gámez; Héctor Pérez-Montoyo; Marc Yeste-Velasco; Carles Domenech; Jose Alberto Alfon

Apr 27, 2023